4//SEC Filing
Kirsch Arthur S 4
Accession 0001104659-21-136408
CIK 0001557142other
Filed
Nov 8, 7:00 PM ET
Accepted
Nov 9, 5:40 PM ET
Size
14.0 KB
Accession
0001104659-21-136408
Insider Transaction Report
Form 4
Kirsch Arthur S
Director
Transactions
- Disposition to Issuer
Stock Option (right to buy)
2021-11-09$5.92/sh−96,975$574,092→ 0 totalExercise: $3.58Exp: 2031-05-12→ Common Stock, par value $0.001 (96,975 underlying) - Disposition to Issuer
Common Stock
2021-11-09$9.50/sh−30,000$285,000→ 0 total - Disposition to Issuer
Stock Option (right to buy)
2021-11-09$7.21/sh−100,000$721,000→ 0 totalExercise: $2.29Exp: 2029-05-15→ Common Stock, par value $0.001 (100,000 underlying) - Disposition to Issuer
Stock Option (right to buy)
2021-11-09$7.21/sh−64,103$462,183→ 0 totalExercise: $2.29Exp: 2029-05-15→ Common Stock, par value $0.001 (64,103 underlying) - Disposition to Issuer
Stock Option (right to buy)
2021-11-09$5.06/sh−85,034$430,272→ 0 totalExercise: $4.44Exp: 2030-05-13→ Common Stock, par value $0.001 (85,034 underlying)
Footnotes (3)
- [F1]Disposed pursuant to the acquisition by Sanofi of the entire issued share capital of Issuer on November 9, 2021 by means of a plan of merger (the "Merger").
- [F2]In connection with the Merger, all unvested stock options ("Options") were accelerated to full vesting and cancelled in exchange for a payment equal to $9.50 with respect to each share of Common Stock subject to such Option.
- [F3]Represents the payment per share of Common Stock received in exchange for the cancellation of each Option.
Documents
Issuer
Kadmon Holdings, Inc.
CIK 0001557142
Entity typeother
Related Parties
1- filerCIK 0001290976
Filing Metadata
- Form type
- 4
- Filed
- Nov 8, 7:00 PM ET
- Accepted
- Nov 9, 5:40 PM ET
- Size
- 14.0 KB